| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $43.8M | +589.9% |
| R&D Expense | $56.0M | +36.0% |
| SG&A Expense | $29.7M | +19.9% |
| Operating Income | -$42.0M | +30.7% |
| Pre-tax Income | -$35.0M | +39.8% |
| Income Tax | $0 | — |
| Net Income | -$35.0M | +39.8% |
| EPS (Basic) | -$4.19 | -284.4% |
| EPS (Diluted) | -$4.19 | -284.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $137.5M | +148.7% |
| Current Assets | $145.0M | +140.8% |
| Total Assets | $154.7M | +117.6% |
| Current Liabilities | $56.3M | +106.4% |
| Total Liabilities | $119.4M | +123.3% |
| Stockholders' Equity | $35.3M | +100.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.0M | +72.8% |
| Capital Expenditures | $518K | +1338.9% |
| Investing Cash Flow | -$518K | -1338.9% |
| Financing Cash Flow | $87.8M | +200.6% |
| Free Cash Flow | -$5.5M | +70.1% |